JP2019089810A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019089810A5 JP2019089810A5 JP2019018663A JP2019018663A JP2019089810A5 JP 2019089810 A5 JP2019089810 A5 JP 2019089810A5 JP 2019018663 A JP2019018663 A JP 2019018663A JP 2019018663 A JP2019018663 A JP 2019018663A JP 2019089810 A5 JP2019089810 A5 JP 2019089810A5
- Authority
- JP
- Japan
- Prior art keywords
- growth factor
- factor
- protein
- group
- psa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261647814P | 2012-05-16 | 2012-05-16 | |
| US61/647,814 | 2012-05-16 | ||
| US13/488,043 | 2012-06-04 | ||
| US13/488,043 US8809501B2 (en) | 2009-07-27 | 2012-06-04 | Nucleophilic catalysts for oxime linkage |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017109323A Division JP6560712B2 (ja) | 2012-05-16 | 2017-06-01 | オキシム連結のための求核触媒 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020067396A Division JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019089810A JP2019089810A (ja) | 2019-06-13 |
| JP2019089810A5 true JP2019089810A5 (enExample) | 2019-11-07 |
| JP6711935B2 JP6711935B2 (ja) | 2020-06-17 |
Family
ID=48579473
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512831A Active JP6195611B2 (ja) | 2012-05-16 | 2013-05-16 | オキシム連結のための求核触媒 |
| JP2017109323A Active JP6560712B2 (ja) | 2012-05-16 | 2017-06-01 | オキシム連結のための求核触媒 |
| JP2019018663A Active JP6711935B2 (ja) | 2012-05-16 | 2019-02-05 | オキシム連結のための求核触媒 |
| JP2020067396A Active JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
| JP2021215385A Active JP7304402B2 (ja) | 2012-05-16 | 2021-12-29 | オキシム連結のための求核触媒 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512831A Active JP6195611B2 (ja) | 2012-05-16 | 2013-05-16 | オキシム連結のための求核触媒 |
| JP2017109323A Active JP6560712B2 (ja) | 2012-05-16 | 2017-06-01 | オキシム連結のための求核触媒 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020067396A Active JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
| JP2021215385A Active JP7304402B2 (ja) | 2012-05-16 | 2021-12-29 | オキシム連結のための求核触媒 |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP2849795B1 (enExample) |
| JP (5) | JP6195611B2 (enExample) |
| KR (4) | KR102237306B1 (enExample) |
| CN (2) | CN109620963B (enExample) |
| AU (1) | AU2013204754C1 (enExample) |
| BR (1) | BR112014028636B1 (enExample) |
| CA (1) | CA2873756C (enExample) |
| EA (2) | EA035506B1 (enExample) |
| MX (1) | MX360594B (enExample) |
| NZ (4) | NZ701945A (enExample) |
| SG (3) | SG10201911328QA (enExample) |
| WO (2) | WO2013173557A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013204754C1 (en) * | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
| IL266361B2 (en) * | 2016-11-14 | 2024-02-01 | Novartis Ag | Methods and preparations for the treatment of cartilage damage and arthritis |
| JP7002036B2 (ja) * | 2016-11-17 | 2022-01-20 | パナソニックＩｐマネジメント株式会社 | 膜電極接合体および固体酸化物形燃料電池 |
| US11786586B2 (en) | 2016-12-23 | 2023-10-17 | Aoa Dx | Carbohydrate structures and uses thereof |
| CN108503901B (zh) * | 2018-04-17 | 2020-07-07 | 哈尔滨工业大学 | 一种抗菌普鲁兰多糖/壳聚糖复合食品包装膜的制备方法 |
| SG11202107497XA (en) | 2019-01-23 | 2021-08-30 | Regeneron Pharma | Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors |
| US11845989B2 (en) | 2019-01-23 | 2023-12-19 | Regeneron Pharmaceuticals, Inc. | Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors |
| EP4298219A1 (en) | 2021-02-26 | 2024-01-03 | Regeneron Pharmaceuticals, Inc. | Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors |
| EP4491603A1 (en) | 2022-03-07 | 2025-01-15 | Kaneka Corporation | Method for producing granular composition containing glutathione |
| WO2025133203A1 (en) * | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Compounds and methods for a long-lasting pam |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54113492A (en) | 1978-02-24 | 1979-09-05 | Sanyo Chem Ind Ltd | Preparation of glucoprotein derivative |
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
| US5198349A (en) | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
| JPH0387173A (ja) | 1987-09-10 | 1991-04-11 | Teijin Ltd | ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体 |
| US5846951A (en) | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
| NZ256921A (en) | 1992-10-02 | 1996-05-28 | Pharmacia Ab | Formulations of coagulation factor viii and a non-ionic surfactant and their preparation |
| NZ250375A (en) * | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
| WO1994028024A1 (en) * | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
| US5621039A (en) | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
| WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| WO1999003496A1 (en) | 1997-07-21 | 1999-01-28 | The University Of North Carolina At Chapel Hill | Factor ix antihemophilic factor with increased clotting activity |
| US7074878B1 (en) | 1999-12-10 | 2006-07-11 | Harris J Milton | Hydrolytically degradable polymers and hydrogels made therefrom |
| US6413507B1 (en) | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| ES2256234T3 (es) | 2000-05-16 | 2006-07-16 | Lipoxen Technologies Limited | Derivatizacion de proteinas en solucion acuosa. |
| US7265084B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| KR100948532B1 (ko) | 2001-11-07 | 2010-03-23 | 넥타르 테라퓨틱스 | 분지형 중합체 및 그의 공액체 |
| CA2496317C (en) | 2002-09-11 | 2014-02-18 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
| EP1681303B1 (en) | 2002-09-11 | 2013-09-04 | Fresenius Kabi Deutschland GmbH | HASylated polypeptides, especially HASylated erythropoietin |
| ES2512499T3 (es) | 2003-04-08 | 2014-10-24 | Yeda Research And Development Co., Ltd. | Fármacos pegilados reversibles |
| US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US20080206182A1 (en) * | 2003-08-08 | 2008-08-28 | Fresenius Kabi Deutschland Gmbh | Conjugates of a Polymer and a Protein Linked by an Oxime Group |
| EP1654290B1 (en) | 2003-08-12 | 2019-03-13 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| NZ547554A (en) | 2003-12-03 | 2009-09-25 | Biogenerix Ag | Glycopegylated granulocyte colony stimulating factor |
| ES2593318T3 (es) | 2004-08-12 | 2016-12-07 | Lipoxen Technologies Limited | Derivados de ácido siálico |
| US8268967B2 (en) | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
| DK1835938T3 (da) | 2004-12-27 | 2013-11-04 | Baxter Int | Polymer-von Willebrand-faktor-konjugater |
| CN101242858B (zh) | 2005-06-16 | 2012-12-19 | 尼克塔治疗公司 | 具有可降解键的轭合物以及用于制备这种轭合物的聚合物试剂 |
| US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
| EP2059527B1 (en) | 2006-09-01 | 2014-12-03 | Novo Nordisk Health Care AG | Modified glycoproteins |
| BRPI0720282B8 (pt) | 2006-12-15 | 2021-05-25 | Baxalta GmbH | construção proteica, composição farmacêutica, e, kit |
| GB0908393D0 (en) * | 2009-05-15 | 2009-06-24 | Almac Sciences Scotland Ltd | Labelling method |
| AU2010281453C1 (en) * | 2009-07-27 | 2019-08-15 | Takeda Pharmaceutical Company Limited | Blood coagulation protein conjugates |
| EP3081233B1 (en) * | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation of proteins other than blood coagulation proteins |
| DK2598172T3 (da) * | 2010-07-30 | 2019-07-01 | Baxalta GmbH | Nukleofile katalysatorer til oximforbindelse |
| KR101560541B1 (ko) * | 2012-04-13 | 2015-10-19 | 아우토리브 디벨롭먼트 아베 | 에어백 모듈과 스티어링 휠의 조립체 |
| AU2013204754C1 (en) * | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
-
2013
- 2013-04-12 AU AU2013204754A patent/AU2013204754C1/en active Active
- 2013-05-16 MX MX2014013919A patent/MX360594B/es active IP Right Grant
- 2013-05-16 EA EA201790935A patent/EA035506B1/ru not_active IP Right Cessation
- 2013-05-16 EA EA201492115A patent/EA028186B9/ru not_active IP Right Cessation
- 2013-05-16 NZ NZ701945A patent/NZ701945A/en unknown
- 2013-05-16 NZ NZ738844A patent/NZ738844A/en unknown
- 2013-05-16 KR KR1020207013096A patent/KR102237306B1/ko active Active
- 2013-05-16 CN CN201811295900.8A patent/CN109620963B/zh active Active
- 2013-05-16 EP EP13728026.9A patent/EP2849795B1/en active Active
- 2013-05-16 KR KR1020217009701A patent/KR102287040B1/ko active Active
- 2013-05-16 CA CA2873756A patent/CA2873756C/en active Active
- 2013-05-16 BR BR112014028636-1A patent/BR112014028636B1/pt active IP Right Grant
- 2013-05-16 NZ NZ724828A patent/NZ724828A/en unknown
- 2013-05-16 WO PCT/US2013/041300 patent/WO2013173557A1/en not_active Ceased
- 2013-05-16 SG SG10201911328QA patent/SG10201911328QA/en unknown
- 2013-05-16 SG SG10201701780RA patent/SG10201701780RA/en unknown
- 2013-05-16 KR KR1020217024432A patent/KR102326360B1/ko active Active
- 2013-05-16 EP EP21214357.2A patent/EP4019049A1/en active Pending
- 2013-05-16 NZ NZ738846A patent/NZ738846A/en unknown
- 2013-05-16 SG SG11201407597XA patent/SG11201407597XA/en unknown
- 2013-05-16 EP EP13724491.9A patent/EP2849794A1/en not_active Withdrawn
- 2013-05-16 KR KR1020147035113A patent/KR102110622B1/ko active Active
- 2013-05-16 WO PCT/US2013/041280 patent/WO2013173543A1/en not_active Ceased
- 2013-05-16 JP JP2015512831A patent/JP6195611B2/ja active Active
- 2013-05-16 CN CN201380037823.5A patent/CN104487095B/zh active Active
-
2017
- 2017-06-01 JP JP2017109323A patent/JP6560712B2/ja active Active
-
2019
- 2019-02-05 JP JP2019018663A patent/JP6711935B2/ja active Active
-
2020
- 2020-04-03 JP JP2020067396A patent/JP7014844B2/ja active Active
-
2021
- 2021-12-29 JP JP2021215385A patent/JP7304402B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019089810A5 (enExample) | ||
| JP2022046676A5 (enExample) | ||
| JP2020111599A5 (enExample) | ||
| JP2022034075A5 (enExample) | ||
| JP2015520163A5 (enExample) | ||
| JP2019116500A5 (enExample) | ||
| US6617135B1 (en) | Multiple cytokine protein complexes | |
| CN103269723B (zh) | 用于偶联水溶性脂肪酸衍生物与蛋白质的材料和方法 | |
| JP2014501262A5 (enExample) | ||
| JP3149182B2 (ja) | 多領域造血刺激因子類 | |
| JP6487328B2 (ja) | アルブミン変異体 | |
| JP2021118723A5 (enExample) | ||
| HRP20190990T1 (hr) | Nukleofilni katalisti za vezanje oksima | |
| Gillies et al. | Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastases | |
| Doherty et al. | Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor | |
| JP5203188B2 (ja) | タンパク質にエフェクター分子を結合させる方法 | |
| CN103403166B (zh) | 新的杂合启动子及包含其的重组载体 | |
| WO1996010089A1 (en) | Modification of peptide and protein | |
| JP2013523145A (ja) | アルブミン誘導体及び変異体 | |
| CN104487095B (zh) | 用于肟键联的亲核性催化剂 | |
| Zhang et al. | Development and biological activity of long-acting recombinant human interferon-α2b | |
| US20040053368A1 (en) | Collagen-binding hybrid polypeptide | |
| KR20030051821A (ko) | 원핵세포에서의 단백질 대량 생산 방법 | |
| JP7635148B2 (ja) | 連続ブレードインペラ | |
| JP2708141B2 (ja) | ヒトインターフェロン−β２Ａ及びヒトインターフェロン−β２Ｂ、該インターフェロンをコードする遺伝子を含むベクター、該インターフェロンを産生するセルライン及び該インターフェロンの医薬品としての用途 |